---
title: Insights | Stefan Randl
description: Stefan Randl joined Siegfried in January 2025 as Chief Scientific Officer. Prior to joining Siegfried, he spent 16 years at Evonik, where he held various leadership positions in several regions, most recently as Vice President Innovation Management Health Care, based in Frankfurt, Germany, and as Vice President Drug Substance, based in Indiana, US. He also headed Sales & Services for Health Care in Asia, based in Tokyo. He holds a PhD in Organic Chemistry from the Technische Universität Berlin.
---

This is a search field with an auto-suggest feature attached.

- There are no suggestions because the search field is empty.

- [Careers](https://www.siegfried.ch/careers/)
- [Media](https://www.siegfried.ch/media/)
- [Investors](https://www.siegfried.ch/investors/)
- [Contact us](https://www.siegfried.ch/contact/)

[Company](https://www.siegfried.ch/company/)

Company

[Purpose](https://www.siegfried.ch/company/purpose/)

[Strategy](https://www.siegfried.ch/company/strategy/)

[Leadership](https://www.siegfried.ch/company/leadership/)

[History](https://www.siegfried.ch/company/history/)

[Locations](https://www.siegfried.ch/company/locations/)

[Offering](https://www.siegfried.ch/offering/)

Offering

[Drug Substances](https://www.siegfried.ch/offering/drug-substances/)

[Exclusive synthesis](https://www.siegfried.ch/offering/drug-substances/exclusive-synthesis/) [API portfolio](https://www.siegfried.ch/offering/drug-substances/api/) [Reference standards](https://www.siegfried.ch/reference-standards/) [Preclinical and early-phase development](https://content.siegfried.ch/siegfried-acceleration-hub) [Alkaloid raw materials extraction](https://extractas.com.au/)

[Drug Products](https://www.siegfried.ch/offering/drug-products/)

[Oral solid dosage forms](https://www.siegfried.ch/offering/drug-products/oral-solids/) [Sterile injectables](https://www.siegfried.ch/offering/drug-products/sterile-injectables/) [Ophthalmics](https://www.siegfried.ch/offering/drug-products/ophthalmics/) [Inhalation products](https://www.siegfried.ch/offering/drug-products/inhalatives/) [Viral vectors](https://dinamiqs.com/)

[Technologies](https://www.siegfried.ch/technologies/)

[Sustainability](https://www.siegfried.ch/sustainability/)

Sustainability

[People](https://www.siegfried.ch/sustainability/people/)

[Environment](https://www.siegfried.ch/sustainability/environment/environment/)

[Integrity](https://www.siegfried.ch/sustainability/integrity/)

[Quality](https://www.siegfried.ch/sustainability/quality/)

[Community engagement](https://siegfried.ch/sustainability/community-engagement/)

[Risk management](https://www.siegfried.ch/sustainability/risk-management/)

[Insights](https://content.siegfried.ch/insights)

[![](https://content.siegfried.ch/hubfs/siegfried-logo.svg)](https://www.siegfried.ch/)

What are you  
looking for?

[![](https://content.siegfried.ch/hubfs/siegfried-logo.svg)](https://www.siegfried.ch/)

[Company](https://www.siegfried.ch/company/)

[Purpose](https://www.siegfried.ch/company/purpose/)

[Strategy](https://www.siegfried.ch/company/strategy/)

[Leadership](https://www.siegfried.ch/company/leadership/)

[History](https://www.siegfried.ch/company/history/)

[Locations](https://www.siegfried.ch/company/locations/)

[Offering](https://www.siegfried.ch/offering/)

[Drug Substances](https://www.siegfried.ch/offering/drug-substances/)

[Exclusive synthesis](https://www.siegfried.ch/offering/drug-substances/exclusive-synthesis/) [API portfolio](https://www.siegfried.ch/offering/drug-substances/api/) [Reference standards](https://www.siegfried.ch/reference-standards/) [Preclinical and early-phase development](https://content.siegfried.ch/siegfried-acceleration-hub) [Alkaloid raw materials extraction](https://extractas.com.au/)

[Drug Products](https://www.siegfried.ch/offering/drug-products/)

[Oral solid dosage forms](https://www.siegfried.ch/offering/drug-products/oral-solids/) [Sterile injectables](https://www.siegfried.ch/offering/drug-products/sterile-injectables/) [Ophthalmics](https://www.siegfried.ch/offering/drug-products/ophthalmics/) [Inhalation products](https://www.siegfried.ch/offering/drug-products/inhalatives/) [Viral vectors](https://dinamiqs.com/)

[Technologies](https://www.siegfried.ch/technologies/)

[Sustainability](https://www.siegfried.ch/sustainability/)

[People](https://www.siegfried.ch/sustainability/people/)

[Environment](https://www.siegfried.ch/sustainability/environment/environment/)

[Integrity](https://www.siegfried.ch/sustainability/integrity/)

[Quality](https://www.siegfried.ch/sustainability/quality/)

[Community engagement](https://siegfried.ch/sustainability/community-engagement/)

[Risk management](https://www.siegfried.ch/sustainability/risk-management/)

[Insights](https://content.siegfried.ch/insights)

- [Careers](https://www.siegfried.ch/careers/)
- [Media](https://www.siegfried.ch/media/)
- [Investors](https://www.siegfried.ch/investors/)
- [Contact us](https://www.siegfried.ch/contact/)

# Insights

## See our event recap

<iframe data-hsv-src="https://play-eu1.hubspotvideo.com/v/143616667/id/292584136913?play_button_color=ffffff" referrerpolicy="origin" sandbox="allow-forms allow-scripts allow-same-origin allow-popups" allow="autoplay; fullscreen;" style="position: absolute !important; width: 100% !important; height: 100% !important; left: 0; top: 0; border: 0 none; pointer-events: initial" title="HubSpot Video" loading="lazy" data-hsv-id="292584136913" data-hsv-play-button-color="ffffff" data-hsv-width="1920" data-hsv-height="1080" data-hsv-full-width="false"></iframe>

Filter by tags

[Technology](https://content.siegfried.ch/insights/tag/technology) [Early-phase development](https://content.siegfried.ch/insights/tag/early-phase-development) [Sustainability](https://content.siegfried.ch/insights/tag/sustainability) [Drug Products](https://content.siegfried.ch/insights/tag/drug-products) [Oral solid dosage form](https://content.siegfried.ch/insights/tag/oral-solid-dosage-form)

[Technology](https://content.siegfried.ch/insights/tag/technology) [Early-phase development](https://content.siegfried.ch/insights/tag/early-phase-development) [Sustainability](https://content.siegfried.ch/insights/tag/sustainability) [Drug Products](https://content.siegfried.ch/insights/tag/drug-products) [Oral solid dosage form](https://content.siegfried.ch/insights/tag/oral-solid-dosage-form) [Regulatory support](https://content.siegfried.ch/insights/tag/regulatory-support) [Scale-up](https://content.siegfried.ch/insights/tag/scale-up)

NEW

 03/23/2026

### From lab to launch: Cutting time in pharmaceutical development

[Read article](https://content.siegfried.ch/insights/from-lab-to-launch-cutting-time-in-pharmaceutical-development)

Recent

#### [Jul 23, 2026 Scale-up Drug Products Dosage form scale-up: Balancing speed and efficiency in later-stage development](https://content.siegfried.ch/insights/dosage-form-scale-up-balancing-speed-and-efficiency-in-later-stage-development)

#### [Jul 8, 2026 Early-phase development Regulatory support Navigating the complex route to regulatory compliance, from preclinical to market](https://content.siegfried.ch/insights/navigating-the-complex-route-to-regulatory-compliance-from-preclinical-to-market)

#### [Jun 22, 2026 Scale-up Drug Products The need for speed: Early-stage dosage form development](https://content.siegfried.ch/insights/the-need-for-speed-early-stage-dosage-form-development)

#### Subscribe for more expert insights

 

All posts

### [Mar 23, 2026 From lab to launch: Cutting time in pharmaceutical development](https://content.siegfried.ch/insights/from-lab-to-launch-cutting-time-in-pharmaceutical-development)

Oct 30, 2025

### Video: Insights from Chief Scientific Officer Stefan Randl at CPHI Frankfurt 2025

Sign up to stay up to date on Siegfried and our business performance.

 expect more

**Siegfried AG**

Untere Brühlstrasse 4  
4800 Zofingen, Switzerland

[+41 62 746 11 11](tel:+41627461111) [Get in touch](https://www.siegfried.ch/contact-us/)

#### About us

- [Our company](https://www.siegfried.ch/company/)
- [Sustainability](https://www.siegfried.ch/sustainability/)
- [Media](https://www.siegfried.ch/media/)
- [Investors](https://www.siegfried.ch/investors/)
- [Careers](https://www.siegfried.ch/careers/)

#### Helpful resources

- [Expert insights](https://content.siegfried.ch/insights)
- [News archive](https://www.siegfried.ch/news-archive/)
- [Reports](https://www.siegfried.ch/investors/investors-download-center-2025/)
- [Terms and conditions](https://www.siegfried.ch/terms-and-conditions/)

#### Offering

- [Drug Substances](https://www.siegfried.ch/offering/drug-substances/)
- [Drug Products](https://www.siegfried.ch/offering/drug-products/)
- [Technologies](https://www.siegfried.ch/technologies/)

2026 © Siegfried Holding AG

<https://www.linkedin.com/company/50322/admin/feed/posts/>

- [Privacy Policy](https://www.siegfried.ch/privacy-policy/)
- [Legal disclaimer](https://www.siegfried.ch/legal-disclaimer/)
- [Imprint](https://www.siegfried.ch/imprint/)

```json
{
  "@context" : "https://schema.org",
  "@type" : "VideoObject",
  "contentUrl" : "https://143616667.fs1.hubspotusercontent-eu1.net/hubfs/143616667/Peter%20-%20Video%2001%20Final%20v2.mp4",
  "dateModified" : "2025-10-31T17:20:09.538Z",
  "duration" : "PT2M16S",
  "height" : 1080,
  "name" : "Peter - Video 01 Final v2",
  "thumbnailUrl" : "https://143616667.fs1.hubspotusercontent-eu1.net/hubfs/143616667/Peter%20-%20Video%2001%20Final%20v2.mp4/medium.jpg",
  "uploadDate" : "2025-10-28T21:59:19.239Z",
  "width" : 1920
}
```